
GSUN Valuation
Golden Sun Health Technology Group Ltd
- Overview
- Forecast
- Valuation
- Earnings
GSUN Relative Valuation
GSUN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GSUN is overvalued; if below, it's undervalued.
Historical Valuation
Golden Sun Health Technology Group Ltd (GSUN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Golden Sun Health Technology Group Ltd (GSUN) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:2.77
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Golden Sun Health Technology Group Ltd. (GSUN) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Golden Sun Health Technology Group Ltd. (GSUN) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Golden Sun Health Technology Group Ltd. (GSUN) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Golden Sun Health Technology Group Ltd. (GSUN) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Golden Sun Health Technology Group Ltd. (GSUN) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Golden Sun Health Technology Group Ltd (GSUN) has a current Price-to-Book (P/B) ratio of -1.48. Compared to its 3-year average P/B ratio of 8.51 , the current P/B ratio is approximately -117.37% higher. Relative to its 5-year average P/B ratio of 11.05, the current P/B ratio is about -113.39% higher. Golden Sun Health Technology Group Ltd (GSUN) has a Forward Free Cash Flow (FCF) yield of approximately -188.19%. Compared to its 3-year average FCF yield of -68.66%, the current FCF yield is approximately 174.06% lower. Relative to its 5-year average FCF yield of -64.95% , the current FCF yield is about 189.74% lower.
-1.48
P/B
Median3y
8.51
Median5y
11.05
-188.19
FCF Yield
Median3y
-68.66
Median5y
-64.95
Competitors Valuation Multiple
The average P/S ratio for GSUN's competitors is 0.10, providing a benchmark for relative valuation. Golden Sun Health Technology Group Ltd Corp (GSUN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of GSUN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of GSUN in the past 1 year is driven by Unknown.
People Also Watch

TNON
Tenon Medical Inc
1.470
USD
+3.52%

LXEH
Lixiang Education Holding Co Ltd
1.280
USD
0.00%

VERB
Verb Technology Company Inc
21.080
USD
0.00%

SNGX
Soligenix Inc
3.560
USD
-28.23%

EJH
E-Home Household Service Holdings Ltd
1.380
USD
0.00%

YGMZ
MingZhu Logistics Holdings Ltd
0.720
USD
0.00%

MBRX
Moleculin Biotech Inc
0.600
USD
-1.15%

EDSA
Edesa Biotech Inc
2.272
USD
0.00%

SBFM
Sunshine Biopharma Inc
1.470
USD
0.00%
FAQ

Is Golden Sun Health Technology Group Ltd (GSUN) currently overvalued or undervalued?
Golden Sun Health Technology Group Ltd (GSUN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Golden Sun Health Technology Group Ltd (GSUN) is between to according to relative valuation methord.

What is Golden Sun Health Technology Group Ltd (GSUN) fair value?

How does GSUN's valuation metrics compare to the industry average?

What is the current P/B ratio for Golden Sun Health Technology Group Ltd (GSUN) as of Aug 19 2025?

What is the current FCF Yield for Golden Sun Health Technology Group Ltd (GSUN) as of Aug 19 2025?

What is the current Forward P/E ratio for Golden Sun Health Technology Group Ltd (GSUN) as of Aug 19 2025?
